Arthritis Research & Therapy

official impact factor 4.36
Search for
Advanced search
Arthritis Research & Therapy
Tools
Open Access Highly Access

Oxaliplatin retains HMGB1 intranuclearly and ameliorates collagen type II-induced arthritis

Therese Östberg*, Heidi Wähämaa, Karin Palmblad, Norimasa Ito, Pernilla Stridh, Maria Shoshan, Michael T Lotze, Helena E Harris and Ulf Andersson

Arthritis Research & Therapy 2008, 10:R1 doi:10.1186/ar2347

Accesses  

  • Last 30 days: 45 accesses
  • Last year: 622 accesses
  • All time: 4840 accesses

Cited by

BioMed Central: 2 citations

Review   Free Highly Accessed

High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease

David S Pisetsky, Helena Erlandsson-Harris, Ulf Andersson Arthritis Research & Therapy 2008, 10:209 (30 June 2008)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Research article   Open Access Highly Accessed

Systemic TNF blockade does not modulate synovial expression of the pro-inflammatory mediator HMGB1 in rheumatoid arthritis patients – a prospective clinical study

Erik Sundberg, Cecilia Grundtman, Erik af Klint, Johan Lindberg, Sofia Ernestam, Ann-Kristin Ulfgren, Helena Harris, Ulf Andersson Arthritis Research & Therapy 2008, 10:R33 (17 March 2008)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central | F1000 Medicine | Editor’s summary

Expression of the pro-inflammatory high mobility group box chromosomal protein 1 did not change in any consistent manner over 9 weeks of anti-TNF therapy in nine rheumatoid arthritis patients.

Google Scholar: View citations

ISI Web of Science: View citations

PubMed Central: View citations